Literature DB >> 11322379

Pathogenesis of edema formation in the nephrotic syndrome.

J G Vande Walle1, R A Donckerwolcke.   

Abstract

Based on observations in 110 children with nephrotic syndrome (NS) and data from the literature, existing concepts on the pathogenesis of edema formation in the NS have been modified. The data suggest that the basic abnormality is a primary disturbance in renal sodium excretion. Depending on the stage in the development of the NS, the rate of progression in the development of hypoproteinemia, and the absolute levels of plasma oncotic pressure, functional hypovolemia may develop, resulting in stimulation of hemostatic mechanisms and secondary sodium retention. This applies as much to patients with minimal change NS as to patients with histological lesions. Alterations in kidney function (glomerular filtration rate, renal plasma flow, filtration fraction) in the NS cannot be explained by hypo- or hypervolemia, but reflect variations in plasma oncotic pressure and glomerular basement membrane permeability. These abnormalities will also influence sodium excretion. Evaluation of the presence of functional hypovolemia will have therapeutic consequences. A quick diagnosis can be made by assessment of FENa+ and UK+/ (UK+ + UNa+) Sodium retention associated with increased distal Na/K exchange indicates functional hypovolemia, and may be treated by albumin infusion if clinically required.

Entities:  

Mesh:

Year:  2001        PMID: 11322379     DOI: 10.1007/s004670000512

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  17 in total

Review 1.  Diuretics in pediatrics : current knowledge and future prospects.

Authors:  Maria M J van der Vorst; Joana E Kist; Albert J van der Heijden; Jacobus Burggraaf
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 2.  Global analysis of gene expression in mammalian kidney.

Authors:  Olga Soutourina; Lydie Cheval; Alain Doucet
Journal:  Pflugers Arch       Date:  2004-12-21       Impact factor: 3.657

3.  A boy with congenital analbuminemia and steroid-sensitive idiopathic nephrotic syndrome: an experiment of nature.

Authors:  Thomas J Neuhaus; Thomas Stallmach; Agnes Genewein
Journal:  Eur J Pediatr       Date:  2007-10-19       Impact factor: 3.183

4.  Circadian Blood Pressure Rhythm Is Changed by Improvement in Hypoalbuminemia and Massive Proteinuria in Patients with Minimal Change Nephrotic Syndrome.

Authors:  Daisaku Ando; Gen Yasuda
Journal:  Cardiorenal Med       Date:  2016-03-01       Impact factor: 2.041

5.  Type of edema in posterior reversible encephalopathy syndrome depends on serum albumin levels: an MR imaging study in 28 patients.

Authors:  A Pirker; L Kramer; B Voller; B Loader; E Auff; D Prayer
Journal:  AJNR Am J Neuroradiol       Date:  2011-01-20       Impact factor: 3.825

6.  Changes of atrial natriuretic Peptide system in rats with puromycin aminonucleoside-induced nephrotic syndrome.

Authors:  Eun Hui Bae; Jongun Lee; Seong Kwon Ma; Soo Wan Kim
Journal:  Korean J Physiol Pharmacol       Date:  2009-02-28       Impact factor: 2.016

7.  Pericardial tamponade in nephrotic syndrome: an uncommon complication.

Authors:  Sunita Namdev; Sriram Krishnamurthy; Niranjan Biswal; Barath Jagadisan
Journal:  Indian J Pediatr       Date:  2012-07-20       Impact factor: 1.967

8.  Changes in endothelin receptor type B and neuronal nitric oxide synthase in puromycin aminonucleoside-induced nephrotic syndrome.

Authors:  Eun Hui Bae; Soo Wan Kim
Journal:  Korean J Physiol Pharmacol       Date:  2010-08-31       Impact factor: 2.016

9.  Randomized cross-over trial comparing albumin and frusemide infusions in nephrotic syndrome.

Authors:  Rajmohan Dharmaraj; Pankaj Hari; Arvind Bagga
Journal:  Pediatr Nephrol       Date:  2009-01-14       Impact factor: 3.714

10.  Treatment of severe edema in children with nephrotic syndrome with diuretics alone--a prospective study.

Authors:  Gaurav Kapur; Rudolph P Valentini; Abubakr A Imam; Tej K Mattoo
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-30       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.